University of Louisville scientists aim to disarm Yersinia pestis, the bubonic plague bacteria

When the body encounters bacteria, viruses or harmful substances, its innate immune cells, neutrophils, assemble at the site to combat the invader.

Healthcare’s Data Deluge is Intensifying Misdiagnosis

Eli Ben-Joseph, co-founder and CEO of Regard In 2019, my aunt was admitted to the hospital with heart failure. It was a harrowing experience for

June 12, 2024

Off-label treatment for alcohol use disorder is linked to slower liver decline, study suggests

WASHINGTON — There are three FDA-approved drugs for treating alcohol use disorder. But a different medication, one frequently used off-label for the condition, could provide

May 22, 2024

Hyivy Health Secures $2M for Pelvic Rehab Platform – FemTech

What You Should Know: The funds are crucial for the advancement of Hyivy Health clinical trials and to prepare for market entry. CEO Rachel Bartholomew

October 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.